Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
339.07
0.00 (0.00%)
Aug 6, 2026, 10:35 AM EDT - Market open
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $9.25 billion as of August 6, 2026. Its market cap has increased by 26.18% in one year.
Market Cap
9.25B
Enterprise Value
9.00B
1-Year Change
26.18%
Ranking
Category
Stock Price
$339.07
ChartMarket Cap Chart
Since August 6, 2021, Bio-Rad Laboratories's market cap has decreased from $22.47B to $9.25B, a decrease of -58.85%. That is a compound annual growth rate of -16.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 9.25B | 13.20% |
| Dec 31, 2025 | 8.17B | -11.01% |
| Dec 31, 2024 | 9.18B | -1.27% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 0.65% |
| Aug 6, 2021 | 22.47B | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zimmer Biomet Holdings | 18.99B |
| Penumbra | 12.73B |
| Smith & Nephew | 12.56B |
| Globus Medical | 10.93B |
| Glaukos | 10.08B |
| Bio-Rad Laboratories | 9.30B |
| Insulet | 9.23B |
| Bruker | 7.99B |